- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Marcus Maurer
Total 3723 results
-
Aarhus University HospitalCompletedHepatitis C, Chronic | Cognition Disorders | Major Depressive Disorder | Fatigue Syndrome, ChronicDenmark
-
University of AarhusAarhus University HospitalWithdrawn
-
Aarhus University HospitalUniversity of AarhusCompletedEssential Hypertension | High Blood PressureDenmark
-
University of AarhusAarhus University HospitalUnknownAscending Aorta AneurismDenmark
-
Aarhus University HospitalCompleted
-
Aarhus University HospitalCompleted
-
University of AarhusAarhus University HospitalCompletedTemporomandibular Joint DisorderDenmark
-
University of AarhusAarhus University HospitalCompleted
-
Marius HenriksenCompleted
-
Marius HenriksenCompletedRespiratory DiseaseDenmark
-
Marius HenriksenCompletedKnee OsteoarthritisDenmark
-
Tarsus UniversityRecruitingNewborn; Vitality | Hyperbilirubinemia, NeonatalTurkey
-
Tarsus UniversityNot yet recruiting
-
Magnus MedicalRecruiting
-
Marinus PharmaceuticalsNot yet recruiting
-
Amicus TherapeuticsRecruitingGlycogen Storage Disease Type II Infantile OnsetUnited States, Taiwan, France, Germany, Italy, United Kingdom
-
Marinus PharmaceuticalsTerminated
-
Marinus PharmaceuticalsActive, not recruitingTuberous Sclerosis ComplexUnited States, Spain, United Kingdom, Israel, Italy, Germany, France, Canada
-
Amicus TherapeuticsActive, not recruitingPompe DiseaseUnited States, Netherlands, United Kingdom, Australia, Germany, New Zealand
-
Amicus TherapeuticsActive, not recruitingFabry DiseaseUnited States, United Kingdom
-
Tarsus UniversityCompletedFear | Child, Only | Respiratory DiseaseTurkey
-
Amicus TherapeuticsCompletedPompe Disease (Late-onset)United States, Australia, Korea, Republic of, Japan, Taiwan, Belgium, Slovenia, New Zealand, United Kingdom, France, Argentina, Canada, Spain, Bosnia and Herzegovina, Germany, Sweden, Hungary, Austria, Bulgaria, Denmark, Greece, I... and more
-
Marinus PharmaceuticalsTerminatedDrug Resistant Partial Onset SeizureUnited States
-
Amicus TherapeuticsCompletedFabry DiseaseJapan, Taiwan, Turkey, United States, Brazil
-
Marinus PharmaceuticalsCompletedCDKL5 Deficiency DisorderUnited States, Australia, France, Israel, Italy, Poland, Russian Federation, United Kingdom
-
Marinus PharmaceuticalsCompletedEpilepsyUnited States, Italy
-
Marinus PharmaceuticalsCompletedPartial Epilepsy | Catamenial EpilepsyUnited States
-
Marinus PharmaceuticalsCompletedDrug Resistant Partial Onset SeizureUnited States, Australia, Russian Federation, Bulgaria, Germany, Poland
-
Marinus PharmaceuticalsCompleted
-
Amicus TherapeuticsTerminatedBatten Disease | Neuronal Ceroid Lipofuscinosis CLN6 | Neuronal Ceroid Lipofuscinosis CLN3United States
-
Amicus TherapeuticsCompletedVariant Late-Infantile Neuronal Ceroid LipofuscinosisUnited States
-
Amicus TherapeuticsCompletedOpen-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry DiseaseFabry DiseaseUnited States, Austria, United Kingdom, Argentina, Australia, Belgium, Brazil, Canada, Denmark, Egypt, France, Italy, Japan, Spain, Turkey
-
Amicus TherapeuticsTerminatedLate-onset Pompe DiseaseUnited States, Canada, Australia, Belgium
-
Amicus TherapeuticsCompletedFabry DiseaseFrance, Austria, United States, Belgium, Japan, United Kingdom, Denmark, Brazil, Australia, Italy
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States, Italy, Spain, Turkey, Brazil, Canada, United Kingdom, France, Poland, Australia, Egypt, Argentina, Denmark
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States, Australia, France, United Kingdom, Brazil, Canada
-
Amicus TherapeuticsTerminatedFabry DiseaseAustralia, United States, Italy, Spain, Belgium, Turkey, Brazil, Argentina, United Kingdom, Denmark, France, Canada, Egypt
-
Amicus TherapeuticsCompleted
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited States
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited Kingdom, Israel, South Africa, United States
-
Amicus TherapeuticsCompleted
-
Amicus TherapeuticsCompleted
-
Amicus TherapeuticsCompletedGlycogen Storage Disease Type II | Pompe DiseaseUnited States
-
Joanne Kurtzberg, MDThe Marcus FoundationRecruitingMucopolysaccharidosis II | Brain Diseases, Metabolic, Inborn | Adrenoleukodystrophy | Batten Disease | Leukodystrophy, Metachromatic | Leukodystrophy, Globoid Cell | Alpha-Mannosidosis | Tay-Sachs Disease | Pelizaeus-Merzbacher Disease | Sandhoff Disease | Neimann Pick Disease | Sanfilippo MucopolysaccharidosesUnited States
-
Joanne Kurtzberg, MDThe Marcus FoundationTerminated
-
University of AarhusAarhus University HospitalRecruiting
-
University of AarhusAarhus University HospitalRecruitingPeripheral T-cell Lymphoma | NK/T-Cell LymphomaDenmark
-
University of AarhusAarhus University HospitalRecruitingCardiovascular Diseases | Inflammation | Lymphedema | Turner SyndromeDenmark
-
University of AarhusAarhus University HospitalNot yet recruiting
-
Aarhus University HospitalUniversity of AarhusRecruitingIschemic Stroke | Transient Ischemic AttackDenmark